Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Cryptococcal Meningitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

infectious Disease Institute Kampala,Uganda, Kampala, Uganda
Contact: Study coordinator (DAVID MEYA, PhD) · david.meya@gmail.com · +256 772 543 730
Contact: Study coordinator (ELIZABETH NALINTYA, MPH) · enalintya@idi.co.ug · +256 771 321 617
Contact: Principal Investigator (DAVID MEYA, PhD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Platform Trial For Cryptococcal Meningitis (PLATFORM-CM)

Hiv · Cryptococcal Meningitis

Abroad (travel likely)RecruitingPHASE2, PHASE3

Kampala, Uganda · Mbarara, Uganda

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

Idiopathic CD4+ Lymphocytopenia · Cryptococcal Meningitis · Warts

Abroad (travel likely)Recruiting

Bethesda, United States

Fungal Infection Susceptibility

Cryptococcal Infection · Cryptococcal Pneumonia · Pulmonary Cryptococcosis

Abroad (travel likely)Recruiting

Bethesda, United States